Join
Live feed
·
INSIDERFilingvia Quantisnow
Travere Therapeutics Inc. logo

CHIEF FINANCIAL OFFICER Cline Christopher R. sold $56,168 worth of shares (1,745 units at $32.19), decreasing direct ownership by 2% to 111,226 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
TVTX· Travere Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track TVTX (Travere Therapeutics Inc.) and more on Quantisnow.